Phase I and Inpatient Services

Make Faster Decisions with Our Early Phase Clinical Trial Site Network

Your Early Signals. Faster.

Faster early phase data means earlier, more confident decisions for your investigational product.

Most early phase delays are not scientific. They come from operational friction: slow site activation, fragmented vendor coordination, and sites stretched across competing priorities. Flourish Research helps reduce that friction through integrated early phase units that move efficiently from activation through enrollment, giving you timely access to the clinical trial data your program needs while upholding scientific rigor and data quality.

We have experience with:

  • Phase I-IIa, First-in-Human (FIH), PK/PD, SAD/MAD, and bioequivalence studies
  • Healthy volunteer and patient cohort studies
  • Studies across most therapeutic areas, including oncology

Ready to move faster?

Let's Talk About Your Early Phase Program

Speed & Activation

Networked sites and centralized budgeting eliminate multi-site negotiation delays. Our dedicated clinical teams have experience getting their sites activated across a broad range of trials. The result: faster study activation, and earlier access to the signals your program depends on.

Dedicated Inpatient Units

Dedicated overnight units, 24/7 clinical staff, extended-stay capabilities, and robust quality oversight support complex early phase protocols without outside competition for bed space or site resources.

From First-in-Human to Phase IV: One Network

Your FIH data, site knowledge, and participant relationships don't disappear after Phase I. With 30 sites across all phases, consistent data infrastructure, and continuous team involvement, every phase transition costs less time and less ramp-up.

Team Photo

Early Phase Facilities & Equipment

Our early phase infrastructure is built to support complex protocols, close safety monitoring, and efficient sponsor oversight across inpatient and outpatient settings.

  • Dedicated, secure overnight facilities
  • Close proximity to hospital emergency rooms, including 10 beds at our ICU-embedded oncology site
  • Accommodations for sponsor/CROs for onsite observation of dosing/procedures
  • Dietician-planned meals
  • IV infusion dosing/monitoring
  • eDocs, eRegulatory for 24/7 access of data
  • Temperature data logging & phone alert system
  • Limited-access, temperature-controlled drug storage
  • Pharmacy hood
  • Ambient and refrigerated centrifuges
  • -80°C and -20°C freezers
  • ECG, with onsite interpretations
  • Accredited sleep labs
  • YSI equipment for blood glucose analysis
  • Crash carts

Onsite PBMC Processing for Greater Sample Control

Flourish Research offers in-house PBMC (Peripheral Blood Mononuclear Cell) services to meet client needs for the evaluation of cellular immune function within the clinical trial setting.

  • Onsite processing eliminates the need for sample transport
  • Network-wide SOPs and quality control
  • Four labs supporting 8 sites across the U.S.
  • High-yield, high-viability cryopreserved (PBMC) cells
  • Oversight by PhD PBMC thought leader

Best-in-class facilities and processes:

  • Temperature-controlled labs
  • Isolation using Ficoll/CPT and/or other isolation techniques
  • Class II A2 biosafety cabinets
  • Fluorescent staining & image analysis
  • Two-step cryopreservation process
  • Long-term storage in vapor phase of liquid nitrogen at -135°C

Let’s talk about your early phase program.

Whether you’re planning a first-in-human study or looking to consolidate a fragmented Phase I footprint, our team can walk you through network capabilities, site specs, and activation timelines.

Name(Required)
Email(Required)
Please let us know any details about your study that would be helpful in getting you connected with the right experts.

Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.